Status:

UNKNOWN

Iscador Qu as Supportive Treatment in Pancreatic Cancer (Union for International Cancer Control, UICC Stages II-IV)

Lead Sponsor:

IFAG AG

Collaborating Sponsors:

Hiscia Society for Cancer Research

IFAG Basel AG, both Switzerland

Conditions:

Pancreas Cancer

Eligibility:

All Genders

18-85 years

Brief Summary

Efficacy and safety of a supportive treatment with European mistletoe extract Iscador® Qu ("quercus", i.e. from oak tree) in patients with pancreatic cancer (Union for International Cancer Control, UI...

Detailed Description

see summary

Eligibility Criteria

Inclusion

  • Confirmed diagnosis of pancreatic cancer, adenocarcinoma, UICC stage II-IV
  • Age between 18 (Austria: 19) and 85 years
  • No previous malign tumor
  • ECOG 0-2
  • Estimated life expectancy \> 3 months
  • Surgical resection of the tumor (R0, R1) or determination of interoperability
  • Conventional oncological therapy and measurements, or passive after-care ("best care")
  • Follow-up for several years feasible
  • Patient gives written consent to use the anonymized date for evaluation

Exclusion

  • Other Iscador® sorts than Qu in the test group
  • Other mistletoe preparations in the test group
  • Any mistletoe preparation in the control group
  • Non-oncological immunomodulating, -stimulating or -suppressive drugs (e.g. Echinacea, interferons, Polyerga®, BCG, azathioprine). Allowed are approved tumor inhibiting immuno- or targeted therapies (e.g. bevacizumab, cetuximab) and tumor specific vaccines
  • HIV infection, Aids, organ transplantation
  • Contraindications for Iscador® Qu (allergy against mistletoe, acute inflammatory disease or fever \> 38.5°C, active tuberculosis, hyperthyreosis with not-adjusted metabolism, primary brain or spinal tumor, brain metastases)
  • Patients participating in another clinical study with non-approved substances

Key Trial Info

Start Date :

September 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 1 2016

Estimated Enrollment :

220 Patients enrolled

Trial Details

Trial ID

NCT01448668

Start Date

September 1 2010

End Date

June 1 2016

Last Update

July 2 2013

Active Locations (9)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (9 locations)

1

5th Med., Clinic Hietzing

Vienna, Austria

2

University Vienna

Vienna, Austria

3

Augusta Clinic

Bochum, Germany

4

MVZ Fulda

Fulda, Germany